Skip to Content


In the US, Micafungin (micafungin systemic) is a member of the drug class echinocandins and is used to treat Candidemia, Esophageal Candidiasis and Fungal Infection Prophylaxis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antifungal agent

Chemical Name

(4R,5R)-4,5-Dihydroxy-N²-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-ornityl-L-treonyl-trans-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-treonyl-(3R)-3-hydroxy-L-glutaminyl-(3S,4S)-3-hydroxy-4-metyl-L-proline cyclic (6->1) (WHO)

Foreign Names

  • Micafunginum (Latin)
  • Micafungin (German)
  • Micafungine (French)
  • Micafungina (Spanish)

Generic Names

  • Micafungin (OS: BAN, JAN)
  • Micafungin Sodium (OS: USAN, BANM, JAN)
  • FK-463 (IS: Fujisawa)

Brand Names

  • Mycamine
    Astellas, Italy; Astellas, Lithuania; Astellas, Norway; Astellas, Slovenia; Astellas, Slovakia; Hikma, Lebanon
  • Funguard
    Astellas, Japan
  • Mycamine
    Astellas, Canada; Astellas, Switzerland; Astellas, China; Astellas, Czech Republic; Astellas, Denmark; Astellas, Spain; Astellas, Finland; Astellas, France; Astellas, Georgia; Astellas, Greece; Astellas, Hong Kong; Astellas, Croatia (Hrvatska); Astellas, Hungary; Astellas, Indonesia; Astellas, Ireland; Astellas, Iceland; Astellas, South Korea; Astellas, Latvia; Astellas, Philippines; Astellas, Portugal; Astellas, Romania; Astellas, Sweden; Astellas, Thailand; Astellas, Taiwan; Astellas, United States; Astellas Pharma, Germany; Astellas Pharma, United Kingdom; Astellas Pharma, Poland; Astellas Pharma, Singapore; Astellas Pharma Europe, Austria; Astellas Pharma Europe, Netherlands; DKSH, Malaysia


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.